(lp0
S'Oculus Innovative Sciences Announces Corporate Name Change to Sonoma ... GlobeNewswire  - Dec 5, 2016 PETALUMA, Calif., Dec. 05, 2016  -- Oculus Innovative Sciences, Inc. , a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and&nbsp;...'
p1
aS'Sonoma Pharmaceuticals Receives Two New United Arab Emirates Regulatory ... GlobeNewswire  - Apr 12, 2017 PETALUMA, Calif., April 12, 2017  -- Sonoma Pharmaceuticals, Inc. , a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological&nbsp;...'
p2
aS'Sonoma Pharmaceuticals Receives US FDA Clearance of Loyon Skin Descaler for ... GlobeNewswire  - Mar 29, 2017 PETALUMA, Calif., March 29, 2017  -- Sonoma Pharmaceuticals, Inc. , a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of&nbsp;...Depomed, Sonoma Pharmaceuticals, Vertex News Today - Schaeffers Research Sonoma Pharmaceuticals Inc  Shares Are Surging Over 20% After FDA ... - Stock Market Daily'
p3
aS'6.945 MarketWatch - Jan 1, 2017 Sonoma Pharmaceuticals Inc. Watchlist CreateSNOAAlert. Closed. Last Updated: Apr 13, 2017 3:59 p.m.. $ 6.945. -0.185 -2.59%.'
p4
aS'Sonoma Pharmaceuticals Receives Final $1.5 Million Payment From Sale of Latin ... GlobeNewswire  - Mar 23, 2017 PETALUMA, Calif., March 23, 2017  -- Sonoma Pharmaceuticals, Inc. , a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of&nbsp;...'
p5
aS'Sonoma Pharmaceuticals Appoints Marc Umscheid as Chief Strategy and Marketing ... GlobeNewswire  - Jan 31, 2017 PETALUMA, Calif., Jan. 31, 2017  -- Sonoma Pharmaceuticals, Inc. , today announced the appointment of Marc Umscheid as chief strategy and marketing officer.'
p6
aS'BRIEF-Oculus Innovative Sciences announces corporate name change to Sonoma ... Reuters - Dec 5, 2016 DUBAI, April 9 Saudi Arabia has included a disclosure on credit risk retention requirements, part of the U.S. Dodd-Frank Act, in the prospectus of a debut dollar sukuk which it is expected to issue this week and could total $10 billion.'
p7
aS'Zacks: Analysts Set $9.00 Price Target for Sonoma Pharmaceuticals Inc  The Cerbat Gem - Apr 16, 2017 Sonoma Pharmaceuticals logo Sonoma Pharmaceuticals Inc  has earned a consensus broker rating score of 1.00  from the one brokers that provide coverage for the company, Zacks Investment Research reports.The Zacks: Sonoma Pharmaceuticals Inc  Receives Average Rating of ... - Petro Global News 24'
p8
aS'Sonoma Pharmaceuticals Reports Financial Results for Fiscal Third Quarter 2017 GlobeNewswire  - Feb 9, 2017 09, 2017  -- Sonoma Pharmaceuticals, Inc. , a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced&nbsp;...'
p9
aS'Sonoma Pharmaceuticals Announces Results from SebuDerm Gel Study in ... GlobeNewswire  - Mar 16, 2017 PETALUMA, Calif., March 16, 2017  -- Sonoma Pharmaceuticals, Inc. , a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of&nbsp;...'
p10
a.